Molnupiravir in COVID-19: A systematic review of literature

BACKGROUND AND AIMS: Molnupiravir is a newer oral antiviral drug that has recently been tested in COVID-19. We aim to conduct a systematic review of literature to find out the efficacy and safety of molnupiravir in patients with COVID-19. METHODS: We systematically searched the electronic database o...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Awadhesh Kumar, Singh, Akriti, Singh, Ritu, Misra, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556684/
https://www.ncbi.nlm.nih.gov/pubmed/34742052
http://dx.doi.org/10.1016/j.dsx.2021.102329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556684/
https://www.ncbi.nlm.nih.gov/pubmed/34742052
http://dx.doi.org/10.1016/j.dsx.2021.102329

Ejemplares similares